Clinical Trials Browser

Recruiting × obinutuzumab × Sarcoma × Clear all

NCT04889716 2026-03-18

CAR-T Followed by Bispecific Antibodies

Phase 2 Recruiting

Dendritic Cell Sarcoma, Interdigitating